| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |